The prognostic significance of CA 125 half-life in patients with ovarian cancer who have received primary chemotherapy after surgical cytoreduction

Authors:
  • LDLee Daly
    Lee Daly
  • MHMichael Helms
    Michael Helms
  • JSJohn T. Soper
    John T. Soper
  • ABAndrew Berchuck
    Andrew Berchuck
  • DCDaniel L. Clarke-Pearson
    Daniel L. Clarke-Pearson

Abstract
No abstract available

This publication has 7 references indexed in Scilit: